Supplier Type
- Trader
- Manufacturer
- contract manufacturer
- Reagent
- custom synthesis
Supplier Region
- Mumbai(5)
- Tamil Nadu(2)
- Hyderabad(8)
- Maharashtra(9)
- Andhra Pradesh(1)
- Gujarat(2)
- New Delhi(1)
- Bangalore(2)
- Vadodara(1)
- Karnataka(1)
- Ujjain(1)
Purity
- NLT 95%
- 99%
- 98+
- 98.26%
- 98%+
- 97-99%
- 97.14%
- 97%
- >97%
- 95.00%
- 90 % Above
- 25 MG 50 MG 100 MG 250 MG EXTRA
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 95NLT %
- 250250 mg.
-
Citalopram hydrobromide
59729-32-7
-
3-Indoxyl phosphate, di-p-toluidinium salt
103404-81-5
-
Naphtha standard mix
-
2-Bromoethylamine hydrobromide
2576-47-8
-
Galantamine Hydrobromide
1953-04-4
-
Citalopram
59729-33-8
-
Dextromethorphan hydrobromide
125-69-9
-
Pyridin-4-ylmethanol hydrobromide
65737-59-9
-
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate
1440961-11-4
-
Citalopram Related Compound B
1332724-03-4
Citalopram hydrobromide 59729-32-7
Citalopram hydrobromide 59729-32-7
2-Bromoethylamine hydrobromide 2576-47-8
Galanthamine Hydrobromide 1953-04-4
2-Bromoethylamine hydrobromide 2576-47-8
Citalopram 59729-33-8
Dextromethorphan hydrobromide 125-69-9
CITALOPRAM EP IMPURITY C 1440961-11-4